[Acute pulmonary edema associated with the use of beta2-mimetic tocolytic agents].
A case of severe pulmonary oedema during beta2-adrenergic agonist tocolytic therapy (salbutamol) in a pregnant woman admitted for preterm labor at 32 weeks of amenorrhoea is reported. Echocardiography and haemodynamic investigations did not show any left ventricular systolic or diastolic dysfunction. Pulmonary oedema is an exceptional complication of beta2-adrenergic agonist tocolytic therapy. The diagnosis is considered in pregnant patients presenting with respiratory distress, associated with or following tocolytic therapy. Anaesthetic management of patients treated with a beta2-adrenergic agonist should take into consideration the delay between discontinuation of tocolytic therapy and anaesthetic induction, as well as volume expansion.
Samet
A
A
Département d'anesthésie-réanimation, CHU Brabois, Vandoeuvre-les-Nancy, France.
Bayoumeu
F
F
Longrois
D
D
Laxenaire
M C
MC
D000208:Acute Disease; D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000328:Adult; D000420:Albuterol / Q000009:adverse effects*; D000773:Anesthesia, Obstetrical; D004417:Dyspnea / Q000139:chemically induced; D005260:Female; D006469:Hemoptysis / Q000139:chemically induced; D006801:Humans; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D011175:Positive-Pressure Respiration; D011247:Pregnancy; D011654:Pulmonary Edema / Q000139:chemically induced*; D015149:Tocolytic Agents / Q000009:adverse effects*
D000318:Adrenergic beta-Agonists; D015149:Tocolytic Agents; D000420:Albuterol